Essential role for oncogenic ras in tumour maintenance

Nature

Volumn 400, Issue 6743, 1999, Pages 468-472

  Chin, Lynda ^a,b   Tam, Alice ^a,c   Pomerantz, Jason ^c   Wong, Michelle ^c   Holash, Jocelyn ^e   Bardeesy, Nabeel ^a   Shen, Qlong ^a   O'Hagan, Ronan ^a   Pantginis, Joe ^e   Zhou, Hao ^e   Horner II, James W ^a   Cordon Cardo, Carlos ^d   Yancopoulos, George D ^e   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; GENE EXPRESSION; GENETIC REGULATION; MOUSE; MUTATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; DOXYCYCLINE; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; LYMPHOKINES; MELANOMA; MICE; MICE, SCID; MICE, TRANSGENIC; ONCOGENES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033614962     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/22788     Document Type: Article

References (26)

1. Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235-248 (1991).
2. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
3. Fasano, O., Taparowsky, E., Fiddes, J., Wigler, M. & Goldfarb, M. Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J. Mol. Appl. Genet. 2, 173-180 (1983).
4. Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad. Sci. USA 93, 10933-10938 (1996).
5. Chin, L. et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11, 2822-2834 (1997).
6. Thomson, T. M. et al. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dermatol. 90, 459-466 (1988).
7. Gause, P. R. et al. Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice. Mol. Carcin. 20, 78-87 (1997).
8. Shirasawa, S., Furuse, M., Yokoyama, N. & Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260, 85-88 (1993).
9. Doherty, P. C., Tripp, R. A. & Sixbey, J. W. Evasion of host immune responses by tumours and viruses. Ciba Found. Symp. 187, 245-256 (1994).
10. Bird, I. N., Spragg, J. H., Ager, A. & Matthews, N. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80, 553-560 (1993).
11. Traweek, S. T., Kandalaft, P. L., Mehta, P. & Battifora, H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am. J. Clim. Pathol. 96, 25-31 (1991).
12. Rak, J. et al. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14, 263-277 (1995).
13. Arbiser, J. L. et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl Acad. Sci. USA 94, 861-866 (1997).
14. Okada, F. et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumor-igenicity of human colorectal carcinoma cells. Proc. Natl Acad. Sci. USA 95, 3609-3614 (1998).
15. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
16. Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R. & Giaccia, A. J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56, 3436-3440 (1996).
17. Goldberg, M. A. & Schneider, T. J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355-4359 (1994).
18. Mukhopadhyay, D. et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375, 577-581 (1995).
19. Rak, J. et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55, 4575-4580 (1995).
20. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B. & Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25915-25919 (1995).
21. Larcher, F. et al. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56, 5391-5396 (1996).
22. Ganss, R., Montoliu, L., Monaghan, A. P. & Schutz, G. A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J. 13, 3083-3093 (1994).
23. Valenzuela, D. M. et al. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscule, at the neuromuscular junction, and after injury. Neuron 15, 573-584 (1995).
24. Schreiber-Agus, N. et al. Role of Mxil in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487 (1998).
25. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501 (1992).
26. Cheng, L., Fu, J., Tsukamoto, A. & Hawley, R. G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotech. 14, 606-609 (1996).